Angus Dalgleish

Angus George Dalgleish (born 1950 in Harrow, London)^[1][2] is a specialist in the fields of cancer immunology and HIV/AIDS research.

Education

Initially educated at the Harrow County School for Boys,^[1] Dalgleish received a Bachelor of Medicine and Surgery degree from University College London with an intercalated Bachelor of Science degree in Anatomy.^[1]

After various positions in the United Kingdom, Dalgleish joined the flying doctor service in Mount Isa, Queensland, then progressed through positions at various hospitals in Brisbane, Australia, before moving to the Ludwig Institute for Cancer Research in Sydney.^[1][2]

Medical career

After completion of his training, Dalgleish returned to work in the UK in 1984 at the Institute of Cancer Research,^[1][2] where he helped identify CD4 as the major cellular receptor for HIV.^[3][4][5] In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London,^[1] and in 1994 he was appointed Visiting Professor at the Institute of Cancer Research.

In 1997, he founded Onyvax Ltd., a privately funded biotechnology company developing cancer vaccines, where he holds a position as Research Director.^[6] He is also a member of the medical board in Bionor Pharma.

Politics

Dalgleish is a member of the UK Independence Party and stood as a 2015 general election candidate in Sutton & Cheam,^[7][8] finishing fourth with 10.7% of the vote.^[9]

Partial bibliography

• Dalgleish, Angus; Whelan, M (2005). "Novel immunotherapeutic approaches to prostate cancer". Current Opinion in Molecular Therapeutics (7): 30–34.
• Dalgleish, Angus (1995). "HIV and CD26". Nature Medicine 1 (9): 881–2. doi:10.1038/nm0995-881. PMID 7585208.
• Stephen Ward; David Casey; Marie-Christine Labarthe; Michael Whelan; Angus Dalgleish; Hardev Pandha; Stephen Todryk (September 2002). "Immunotherapeutic potential of whole tumour cells". Cancer Immunology, Immunotherapy 51 (7): 351–357. doi:10.1007/s00262-002-0286-2. PMID 12192534. Retrieved 2008-10-10.
• Improving Outcomes for People with Skin Tumours including Melanoma (PDF). National Institute for Health and Clinical Excellence. February 2006. pp. 525–535.

References

1. "Biography". St. George's University of London. Archived from the original on 2008-06-16. Retrieved 2008-10-10.
2. "Biography". London Oncology Clinic. Archived from the original on 6 October 2008. Retrieved 2008-10-10.
3. Wilks, David; Dalgleish, Angus (1992). Molecular and Cell Biology of Sexually Transmitted Diseases. Springer. p. 283. ISBN 978-0-412-36510-2.
4. "Biography". Hasumi International Research Foundation. Archived from the original on 21 November 2008. Retrieved 2008-10-10.
5. Berridge, Virginia (1996). AIDS in the UK. Oxford University Press. p. 52. ISBN 978-0-19-820473-2.
6. "Corporate Fact Sheet" (PDF). Onyvax Ltd. Retrieved 2008-10-10.
7. "Angus Dalgleish: 2015 Parliamentary Candidate for Sutton & Cheam + Representative for Cheam". UKIP Sutton Borough. Retrieved 2015-04-29.
8. Murphy-Pyle, Mike (4 March 2014). "Cancer expert Professor Angus Dalgleish to stand for UKIP in Sutton and Cheam". Sutton Guardian. Retrieved 2015-04-29.
9. "UK Polling Report". ukpollingreport.co.uk.